Message from the Chief
It was at Mount Sinai that a number of gastrointestinal diseases were first identified or studied with the goal of finding a treatment or cure. These include the first descriptions of Crohn’s disease and benign paroxysmal peritonitis, among many others.
Today, Mount Sinai gastroenterologists care for more patients with inflammatory bowel disease (IBD) then any medical center in the country. Gastroenterologists from throughout the New York tri-state area send their most challenging cases to our IBD physicians. Patients with neuroendocrine tumors from throughout the area and around the country come to Mount Sinai for our expertise in diagnosis and treatment. In addition we have a new, state-of-the-art endoscopy suite to utilize the exceptional diagnostic and treatment skills of our endoscopists.
Our clinicians and researchers are developing new tools for non-invasive diagnosis of gastrointestinal cancers as well as reaching out to the community to develop culturally appropriate means of encouraging cancer screening.
In 1958, the National Institutes of Health recognized the importance of Mount Sinai as a research center with a grant for gastroenterology fellowship training. This prestigious grant was re-awarded in 2000 as a combined GI/Liver training grant, making Icahn School of Medicine the only medical school in the New York metropolitan area granted this specialized award.
Whether you are a current or prospective faculty member, trainee, supporter or patient, it is my hope that as you explore our site and discover all that we have to offer, you will discover the benefits our programs can offer you.
Bruce E. Sands, MD
Chief, Henry D. Janowitz Division of Gastroenterology